The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Advances in Toxoplasma gondii Vaccines: Current Strategies and Challenges for Vaccine Development
Open accessAbstract
Toxoplasmosis, caused by the apicomplexan parasite Toxoplasma gondii, is one of the most damaging parasite-borne zoonotic diseases of global importance. While approximately one-third of the entire world’s population is estimated to be infected with T. gondii, an effective vaccine for human use remains unavailable. Global efforts in pursuit of developing a T. gondii vaccine have been ongoing for decades, and novel innovative approaches have been introduced to aid this process. A wide array of vaccination strategies have been conducted to date including, but not limited to, nucleic acids, protein subunits, attenuated vaccines, and nanoparticles, which have been assessed in rodents with promising results. Yet, translation of these in vivo results into clinical studies remains a major obstacle that needs to be overcome. In this review, we will aim to summarize the current advances in T. gondii vaccine strategies and address the challenges hindering vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“there is no safe and effective vaccine for T. gondii (Chu and Quan, 2021).”
From A novel Toxoplasma gondii TGGT1_316290 mRNA-LNP vaccine elicits protective immune response against toxoplasmosis in mice (2023) · cites this paper as Chu and Quan, 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Howe, D. K., & Sibley, L. D. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.6.1561 · Cited by 1,465
Carbohydrate vaccines: developing sweet solutions to sticky situations?
Astronomo, R. D., & Burton, D. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3012 · Cited by 629
Kushnir, N., Streatfield, S. J., & Yusibov, V. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.083 · Cited by 610
Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice
Dunay, I. R., Gajurel, K., Dhakal, R., Liesenfeld, O., & Montoya, J. G. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00057-17 · Cited by 558
Toxoplasmosis in sheep—The last 20 years
Dubey, J. P. (2009) · Veterinary Parasitology · doi:10.1016/j.vetpar.2009.02.026 · Cited by 514
Chahal, J. S., Khan, O. F., Cooper, C. L., McPartlan, J. S., Tsosie, J. K., Tilley, L. D., Sidik, S. M., Lourido, S., Langer, R., Bavari, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600299113 · Cited by 414
Halonen, S. K., & Weiss, L. M. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53490-3.00008-x · Cited by 380
Recent Advances in Subunit Vaccine Carriers
Vartak, A., & Sucheck, S. J. (2016) · Vaccines · doi:10.3390/vaccines4020012 · Cited by 325
Elbez, A., Ajzenberg, D., Dardé, M., Cohen, R., Dumètre, A., Yera, H., Gondon, E., Janaud, J., & Thulliez, P. (2008) · The Journal of Infectious Diseases · doi:10.1086/595793 · Cited by 321
Vaccination: the cornerstone of an efficient healthcare system
Rémy, V., Zöllner, Y. F., & Heckmann, U. (2015) · Journal of Market Access & Health Policy · doi:10.3402/jmahp.v3.27041 · Cited by 257
Cited by
Sorted by citations
The pathogenicity and virulence of Toxoplasma gondii
Sanchez, S. G., & Besteiro, S. (2021) · Virulence · doi:10.1080/21505594.2021.2012346 · Cited by 151
Toxoplasmosis vaccines: what we have and where to go?
Zhang, Y., Li, D., Lu, S., & Zheng, B. (2022) · npj Vaccines · doi:10.1038/s41541-022-00563-0 · Cited by 77
Advances and Challenges in Diagnostics of Toxoplasmosis in HIV-Infected Patients
Wesołowski, R., Pawłowska, M., Smoguła, M., & Szewczyk‐Golec, K. (2023) · Pathogens · doi:10.3390/pathogens12010110 · Cited by 50
A Comprehensive Review of Toxoplasmosis: Serious Threat to Human Health
Khairullah, A. R., Kurniawan, S. C., Widodo, A., Effendi, M. H., Hasib, A., Silaen, O. S. M., Ramandinianto, S. C., Moses, I. B., Riwu, K. H. P., Yanestria, S. M., et al. (2024) · The Open Public Health Journal · doi:10.2174/0118749445281387240202094637 · Cited by 49
Review of Toxoplasmosis: What We Still Need to Do
Farhab, M., Aziz, M. W., Shaukat, A., Cao, M.-X., Hou, Z., Huang, S., Li, L., & Yuan, Y. (2025) · Veterinary Sciences · doi:10.3390/vetsci12080772 · Cited by 39
Majidiani, H., Pourseif, M. M., Kordi, B., Sadeghi, M.-R., & Najafi, A. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09807-x · Cited by 27
Najm, R., Ruivo, M. T. G., Penarete‐Vargas, D. M., Hamie, M., Mouveaux, T., Gissot, M., Boulanger, M. J., Hajj, H. E., & Lebrun, M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219533120 · Cited by 24
Zhang, Y., Li, D., Shen, Y., Li, S., Lu, S., & Zheng, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161507 · Cited by 23
Li, D., Zhang, Y., Li, S., & Zheng, B. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1145114 · Cited by 22
Modulation of autophagy as a therapeutic strategy for Toxoplasma gondii infection
Cheng, A., Zhang, H., Chen, B., Zheng, S., Wang, H., Shi, Y., You, S., Li, M., & Jiang, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.902428 · Cited by 21
Król, G., Fortunka, K., Majchrzak, M., Piktel, E., Paprocka, P., Mańkowska, A., Lesiak, A., Karasiński, M., Strzelecka, A., Durnaś, B., et al. (2023) · Pathogens · doi:10.3390/pathogens12060838 · Cited by 21
Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
Koger-Pease, C., Perera, D. J., & Ndao, M. (2023) · Pharmaceuticals · doi:10.3390/ph16030334 · Cited by 18
Asghari, A., Majidiani, H., Fatollahzadeh, M., Nemati, T., Shams, M., Azizi, E., & Abdoli, A. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105037 · Cited by 16
Khorshidvand, Z., Khosravi, A., Mahboobian, M. M., Harchegani, A. L., Fallah, M., & Maghsood, A. H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.146 · Cited by 16
Goodswen, S. J., Kennedy, P. J., & Ellis, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-34863-9 · Cited by 16
Brito, C., Lourenço, C. M., Magalhães, J., Reis, S., & Borges, M. C. (2023) · Vaccines · doi:10.3390/vaccines11040733 · Cited by 15
Mining the Proteome of Toxoplasma Parasites Seeking Vaccine and Diagnostic Candidates
Rashidi, S., Sánchez‐Montejo, J., Mansouri, R., Ali‐Hassanzadeh, M., Savardashtaki, A., Bahreini, M. S., Karimazar, M., Manzano-Román, R., & Nguewa, P. (2022) · Animals · doi:10.3390/ani12091098 · Cited by 13
Zhang, Y., Li, S., Chu, H., Li, J., Lu, S., & Zheng, B. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02866-23 · Cited by 12
Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview
Felín, M. S., Wang, K., Moreira, A., Grose, A., Leahy, K., Zhou, Y., Clouser, F. A., Siddiqui, M., Leong, N., Goodall, P., et al. (2022) · Current Pediatrics Reports · doi:10.1007/s40124-022-00269-w · Cited by 12
Sargsyan, T. H., Stepanyan, L., Tsaturyan, A., Palumbo, R., Vicidomini, C., & Roviello, G. N. (2025) · Vaccines · doi:10.3390/vaccines13111082 · Cited by 10
Parasites, Pussycats and Psychosis
Torrey, E. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-86811-6 · Cited by 10
Maltodextrin-Nanoparticles as a Delivery System for Nasal Vaccines: A Review Article
Fasquelle, F., Scuotto, A., Howsam, M., & Betbeder, D. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020247 · Cited by 9
The detection of Toxoplasma gondii ME49 infections in BALB/c mice using various techniques
Kang, H., Mao, J., Kim, M.-J., Yoon, K.-W., Eom, G.-D., Chu, K., Moon, E., & Quan, F. (2023) · Parasites Hosts and Diseases · doi:10.3347/phd.23048 · Cited by 8
Self-citationCampero, L. M., Gual, I., Sander, V. A., Morales, L. F. M., Ramos-Duarte, V. A., Formigo, P. M., Sosa, E. M., Lázaro, F., Scioli, M. V., Atela, A., et al. (2025) · Acta Tropica · doi:10.1016/j.actatropica.2025.107540 · Cited by 8
Zhou, C., Li, L., Huang, C., Guo, X., An, X.-D., Luo, F.-F., & Cong, W. (2022) · Parasites & Vectors · doi:10.1186/s13071-022-05408-2 · Cited by 8
Chyb, M., Ferra, B. T., Kawka, M., Skwarecka, M., Dziadek, B. R., & Gatkowska, J. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1480349 · Cited by 7
Improved ELISPOT protocol for monitoring Th1/Th17 T-cell response following T.gondii infection
Fasquelle, F., Vreulx, A.-C., & Betbeder, D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0301687 · Cited by 6
Mao, J., Eom, G.-D., Yoon, K.-W., Heo, S. I., Kang, H., Chu, K., Moon, E., & Quan, F. (2024) · Acta Tropica · doi:10.1016/j.actatropica.2024.107501 · Cited by 6
Self-citationMadlala, T., Adeleke, V. T., Okpeku, M., Tshilwane, S. I., Adeniyi, A. A., & Adeleke, M. A. (2023) · Vaccine X · doi:10.1016/j.jvacx.2023.100347 · Cited by 6
Berizi, M., Babaie, J., Fard‐Esfahani, P., Enshaeieh, M., Noordin, R., Saadatnia, G., & Golkar, M. (2021) · Iranian Journal of Parasitology · doi:10.18502/ijpa.v16i4.7875 · Cited by 6
Tian, X., Sun, H., Wang, M., Wan, G., Xie, T., Mei, X., Zhang, Z., Li, X., & Wang, S. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.802250 · Cited by 6
Application potential of arecoline hydrobromide for anti-Toxoplasma gondii
Cheng, X., Yan, W., Xu, J., Wang, S., & Jin, C. (2025) · Experimental Parasitology · doi:10.1016/j.exppara.2025.108946 · Cited by 5
Blades and barriers: Oral vaccines for conquering cancers and warding off infectious diseases
Yang, K., Liu, J., Zhao, Y., Xu, H., Zu, M., Li, B., Shi, X., Reis, R. L., Kundu, S. C., & Xiao, B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.038 · Cited by 5
Research on inner membrane complex protein 1: a novel nanovaccines against Toxoplasma gondii
Fang, Y., Zhou, P., Qi, W., Yu, Y., Wang, X., Jiang, Y., Zhang, L., Yu, Y., Wang, J., Yu, Z., et al. (2025) · BMC Veterinary Research · doi:10.1186/s12917-025-04961-z · Cited by 5
la Torre, A. L.-D., Sánchez-Sánchez, R., Diezma‐Díaz, C., Ferre, I., Regidor‐Cerrillo, J., & Ortega‐Mora, L. M. (2025) · Veterinary Research · doi:10.1186/s13567-025-01645-2 · Cited by 5
Saki, J., & Arjmand, R. (2023) · Journal of Parasitic Diseases · doi:10.1007/s12639-023-01601-x · Cited by 5
Mohammadi, M. K., & Ghaffari, A. D. (2025) · Parasite Immunology · doi:10.1111/pim.70004 · Cited by 5
Abou-El-Naga, I. F., Gomaa, M. M., & Achy, S. E. (2021) · Pathogens and Global Health · doi:10.1080/20477724.2021.1967628 · Cited by 5
Mao, J., Kang, H., Heo, S.-I., & Quan, F. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2546769 · Cited by 4
Self-citationShams, M., Heydaryan, S., Bashi, M. C., Gorgani, B. N., Ghasemi, E., Majidiani, H., Nazari, N., & Irannejad, H. (2023) · In Silico Pharmacology · doi:10.1007/s40203-023-00140-w · Cited by 4
Felín, M. S., Wang, K., Moreira, A., Grose, A., Leahy, K., Zhou, Y., Clouser, F. A., Siddiqui, M., Leong, N., Goodall, P., et al. (2022) · Current Pediatrics Reports · doi:10.1007/s40124-022-00268-x · Cited by 4
Ghahari, S. M. M., Ajami, A., Sadeghizadeh, M., Rastaghi, A. R. E., & Mahdavi, M. (2022) · Experimental Parasitology · doi:10.1016/j.exppara.2022.108404 · Cited by 4
Tata Laksana Ensefalitis Toksoplasma pada Penyandang HIV
Chandra, F. A. (2022) · Cermin Dunia Kedokteran · doi:10.55175/cdk.v49i9.296 · Cited by 4
Recent Trends in Toxoplasmosis Diagnosis and Management
Chorawala, M. R., Kothari, N. R., Shah, A. C., Pandya, A. J., Shah, I., & Prajapati, B. G. (2024) · Wiley eBooks · doi:10.1002/9781394188741.ch23 · Cited by 4
Parasite Control Strategies: Immunoprophylaxis
Naz, S., Abbasi, S. W., Walton, S. F., Jaiswal, A. K., & Azevedo, V. (2023) · CABI eBooks · doi:10.1079/9781800621893.0015 · Cited by 4
Li, D., Han, M., Cao, Y., Du, J., & An, R. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.01.050 · Cited by 4
Mathematical model of rabies vaccination in the United States
Hassan, A., Tapp, Z. A., Tran, D. K., Rychtář, J., & Taylor, D. (2024) · Theoretical Population Biology · doi:10.1016/j.tpb.2024.03.004 · Cited by 3
Heo, S. I., Kang, H., Mao, J., Yang, Z., Ahmed, M. A., & Quan, F. (2025) · Vaccines · doi:10.3390/vaccines13080787 · Cited by 3
Self-citationKang, H., & Quan, F. (2025) · Acta Tropica · doi:10.1016/j.actatropica.2025.107812 · Cited by 3
Self-citationYounis, S. S., Gamea, G. A., Maghraby, G. M. E., Arafa, M. F., Khalifa, R. A., Shoeib, S. M., El‐Gohary, R. M., & Elmansory, B. M. (2025) · Experimental Parasitology · doi:10.1016/j.exppara.2025.109024 · Cited by 3
Alshammari, A. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108074 · Cited by 3
Xu, B., Bi, Y., Wang, Y., Sun, J., Chen, J., & Mu, J. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1674435 · Cited by 3
Colloidal Manganese Salt Improves the Efficacy of Toxoplasma gondii Inactivated Vaccine in Mice
Huang, C., Bai, S., Yu, H., Pan, M., Hou, Z., Fu, L., & Huang, S. (2025) · Vaccines · doi:10.3390/vaccines13121230 · Cited by 3
Human T-cell activation with Toxoplasma gondii antigens loaded in maltodextrin nanoparticles
García-López, L., Zamora-Vélez, A., Vargas-Montes, M., Sánchez‐Arcila, J. C., Fasquelle, F., Betbeder, D., & Gómez‐Marín, J. E. (2024) · Life Science Alliance · doi:10.26508/lsa.202302486 · Cited by 3
Bai, S.-Y., Zhou, G.-Q., Li, Y., Ming, P., Fu, L., & Huang, S. (2025) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2024.0159 · Cited by 3
Bekier, A., Gatkowska, J. M., Chyb, M., Sokołowska, J., Chwatko, G., Głowacki, R., Paneth, A., & Dzitko, K. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114812 · Cited by 3
Luo, Y., He, M., Yang, S.-Q., Qian, J., He, Z., Xu, J., Guo, L., Xiao, S., & Fang, R. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70143 · Cited by 2
Hosseini, S. A., Hashemi, S., Siamian, D., Asghari, A., Fathollahzadeh, M., Majidiani, H., Shahraki, I., & Safari, M. H. (2025) · The Microbe · doi:10.1016/j.microb.2025.100622 · Cited by 2
Thevendran, R., & Solayappan, M. (2026) · Biotechnology Journal · doi:10.1002/biot.70185 · Cited by 2
Evolution of Toxoplasma gondii Detection and Genotyping Methods
Kowalczyk, M., Sroka, J., & Wójcik‐Fatla, A. (2026) · Journal of Parasitology Research · doi:10.1155/japr/5586858 · Cited by 2
Qadeer, A., Tharwat, M., Khan, M. Z., Juhász, A., & Alshanbari, F. A. (2026) · Veterinary Sciences · doi:10.3390/vetsci13050437 · Cited by 2
Tian, X., Yang, Z., Wan, G., Xie, T., Wang, M., Sun, H., Mei, X., Zhang, Z., Li, X., & Wang, S. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.957479 · Cited by 2
Deng, M., Gao, F., Liu, T., Zhan, W., Quan, J., Zhao, Z., Wu, X., Zhong, Z., Zheng, H., & Chu, J. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-04839-0 · Cited by 2
Nakayama, Y., Ihara, F., Okuzaki, D., Nishikawa, Y., Sasai, M., & Yamamoto, M. (2024) · Parasitology International · doi:10.1016/j.parint.2024.102995 · Cited by 2
Pathophysiology of Medical Parasites: Mechanisms of Disease and Immune Evasion
Mustafa, H. M. (2024) · European journal of ecology, biology and agriculture. · doi:10.59324/ejeba.2024.1(5).04 · Cited by 2
Pereira, L. M., de Paula, J. A., Baroni, L., Bezerra, M. A., Abreu-Filho, P. G., & Yatsuda, A. P. (2022) · Experimental Parasitology · doi:10.1016/j.exppara.2022.108268 · Cited by 2
Toxoplasmosis and Women’s Reproductive Health
Bagheri, R. B. (2025) · International Journal of Medical Parasitology and Epidemiology Sciences · doi:10.34172/ijmpes.5187 · Cited by 1
Mao, J., Kang, H.-J., Eom, G.-D., Heo, S. I., Nam, H., Lee, J.-H., Park, K.-H., Lee, M. S., Kim, S. S., & Quan, F. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010093 · Cited by 1
Self-citationSuprianto, D., Fitri, L. E., Sabarudin, A., Mahmudy, W. F., Prabowo, M. H., & Surareungchai, W. (2026) · Medical Devices Evidence and Research · doi:10.2147/mder.s569457 · Cited by 1
Multi-epitope mRNA vaccine and protein vaccine protect mice against Toxoplasma gondii
Cui, Y., Qu, H., Zhou, C., Liang, Z., Han, B., Zhou, H., & Cong, H. (2026) · Parasites & Vectors · doi:10.1186/s13071-026-07447-5 · Cited by 1
Borkens, Y. (2021) · Der Internist · doi:10.1007/s00108-021-01155-1 · Cited by 1
Could metformin modulate the outcome of chronic murine toxoplasmosis?
Gomaa, M. M., Achy, S. E., & Hezema, N. N. (2024) · Acta Tropica · doi:10.1016/j.actatropica.2024.107339 · Cited by 1
Toxoplasma gondii and Its Relation to Cancer
Grandes-Blanco, A. I., Sánchez‐Minutti, L., García‐Barrientos, R., & Toledo-Rueda, W. (2024) · Springer eBooks · doi:10.1007/978-3-031-62558-9_11 · Cited by 1
Campero, L. M., Gual, I., Sander, V. A., Morales, L. F. M., Ramos-Duarte, V. A., Formigo, P. M., Sosa, E., Lázaro, F., Scioli, M. V., Atela, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.15.623790 · Cited by 1
Zaher, M. R., & El-Husseini, D. M. (2026) · Research Square · doi:10.21203/rs.3.rs-11527358/v1 · Cited by 1
Sentinel Seals, Safe Cats, and Better Treatments
Torrey, E. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-86811-6_7
Parasitic Vaccines in Dogs and Cats
Munir, F., Shakoor, A., Aleem, M. T., & Sindhu, Z. U. D. (2024) · Wiley eBooks · doi:10.1002/9781394158256.ch20
"Review On: Seroprevalence of Toxoplasma gondii Infection in Women of Child-Bearing Age"
Khanum, H. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.53.008446
Current vaccine candidate of toxoplasmosis
Woldegerima, E., GETACHEW, F., MISGANAW, M., MESFIN, Y., Belete, D., Sisay, T., & Berhane, N. (2024) · Journal of Life Science and Biomedicine · doi:10.54203/jlsb.2024.6
Sarvestani, A. S., Mohammadpour, I., Mohammadi, Z. S., & Asgari, Q. (2025) · Journal of Parasitology Research · doi:10.1155/japr/1666892
Immunogenicity and Protective Efficacy of Toxoplasma gondii SRS67 and SRS20A Proteins in micePreprint
Xiaoxiao, C., Tingting, Y., Wenyu, M., Xuefei, L., Shuaijing, N., Hongwei, L., Mengze, D., Shuanghai, Z., Qiuming, L., & Yin, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.17.688744
Signori, G. F., & Ribeiro, J. V. S. L. (2025) · RCMOS - Revista Científica Multidisciplinar O Saber · doi:10.51473/rcmos.v1i2.2025.1827
Zaki, L., Ghaffarifar, F., Sharifi, Z., & Horton, J. D. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128785
Tian, X., Ma, H., Gao, S., Li, Y., Zhu, B., Zhang, J., Wang, J., Hu, Y., Li, Y., Wang, Q., et al. (2026) · Acta Tropica · doi:10.1016/j.actatropica.2026.108179
(2026) · Continental Veterinary Journal · doi:10.71081/cvj/2026.076
An Immunoinformatic Approach for a Multi‐Epitope Vaccine Against Toxoplasma gondii
Asadi, N., Navapour, L., Mogharrab, N., Yousefi, E., Feizollahzadeh, S., Taheri‐Anganeh, M., Khademvatan, S., & Howarth, G. S. (2026) · Parasite Immunology · doi:10.1111/pim.70095
Coelho, A. C., Saraiva, S., & Simões, J. (2026) · Springer eBooks · doi:10.1007/978-3-031-52133-1_181-1
Zheng, Z., Huang, S.-B., Ma, Y.-R., WEN-bo, H. A. O., Zheng, X.-N., Song, H.-Y., & Zhu, X. (2026) · Microorganisms · doi:10.3390/microorganisms14081725
Yang, Z., Wang, J., Wu, J., Fan, Y., Ying, T., Zhang, H., Bai, J., Wang, Y., Liu, P., Li, G., et al. (2026) · Virulence · doi:10.1080/21505594.2026.2713823
Nasal Nanoparticle Vaccine Induces a Cross-Strain T-Cell Immunity Against Toxoplasma gondii
Lecouffe, A., Bouillet, T., Thiroux, B., Degraeve, A., Vreulx, A.-C., Magnez, R., Scuotto, A., Barnier-Quer, C., & Betbeder, D. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18091109
Zhang, Y., Li, H., Jing, Y., Sun, W., Wei, B., Wei, Z., & Jiang, N. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.01827-26
Aiduenu, A. F., Gayi, B. K., Dofuor, A. K., Anovunga, S. A., Ekloh, W., Osei, J. H. N., Tawiah‐Mensah, C. N. L., Seglah, J., Yamoah, J. A. A., Akomea, A., et al. (2026) · International Journal of Microbiology · doi:10.1155/ijm/3271467
Preliminary study on expression and functions of Toxoplasma gondii SRS67 and SRS20A proteins
陈肖潇, Yi, T., Ma, W., Liang, X., Niu, S., Du, M., Zhou, S., Li, Q., & Yin, D. (2026) · Parasites & Vectors · doi:10.1186/s13071-026-07629-1
El-Husseini, D. M., Abdelmotagly, H., Kassem, S. H., Younis, S. S., Shanawany, E. E. E., & Zaher, M. R. (2026) · Pathogens · doi:10.3390/pathogens15111142
Metadata
- Authors
- Chu, K.-B., & Quan, F.-S.
- Affiliations
- Kyung Hee University (KR)
- Corresponding author
- Quan, Fu-Shi
- Venue
- Vaccines
- Publisher
- MDPI AG
- Published
- 2021-04-21
- Volume
- 9
- Issue
- 5
- Pages
- 413
- ISSN
- 2076-393X (ISSN-L)
- PMC
- PMC8143161
- OpenAlex
- W3152765551
- Cited by
- 92
- References
- 118
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 19 · 2023: 15 · 2022: 13 · 2021: 7
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Vaccines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (NRF) (2018R1A6A1A03025124)
- Ministry of Health & Welfare, Republic of Korea (HV20C0085, HV20C0142)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Toxoplasma gondii Research Studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Coccidia and coccidiosis research
- Life Sciences › Immunology and Microbiology › Parasitology › Parasitic infections in humans and animals
- Keywords
- Toxoplasma gondii, toxoplasmosis, vaccine development, zoonotic parasitic disease, nucleic acid vaccines, subunit vaccine, live attenuated vaccine, nanoparticle vaccine, clinical translation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
